Microfluidics rebrands MRT nanoparticle creation technology as PureNano platform
As leading pharmaceutical companies continue to explore the benefits of continuous manufacturing and bottom-up nanoparticle creation, Microfluidics has rebranded its innovative MRT nanoparticle creation technology as the PureNano™ platform, featuring the PureNano Continuous Crystallizer.
Microfluidics, a wholly owned subsidiary of MFIC Corporation, announces methods for processing bulk carbon nanotubes.